Karyopharm stock falls after announcing $100 million financing deal

view original post

Investing.com — Karyopharm Therapeutics (NASDAQ:KPTI) stock fell 13% after the commercial-stage pharmaceutical company announced strategic financing transactions that will provide $100 million in …